Literature DB >> 10483028

Validation of the medical outcomes study family and marital functioning measures in SLE patients in Singapore.

J Thumboo1, K Y Fong, S P Chan, K H Leong, P H Feng, S T Thio, M L Boey.   

Abstract

OBJECTIVE: To validate the Medical Outcomes Study Family and Marital Functioning Measures (FMM and MFM) in a multi-ethnic, urban Asian population in Singapore.
METHODS: English speaking Chinese, Malay or Indian SLE patients (n=120) completed a self-administered questionnaire containing the FFM and MFM at baseline, after 2 weeks and after 6 months. Lupus activity, disease-related damage and quality of life were assessed using the British Isles Lupus Assessment Group (BILAG), Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index and SF-36 Health Survey respectively. Scale psychometric properties were assessed through factor analysis, Cronbach's alpha, quantifying test-retest differences and known-groups construct validity.
RESULTS: Factor analysis of scores obtained at baseline and after 6 months identified 3 factors corresponding to the FFM (1 factor) and the MFM (2 factors). Both scales showed acceptable internal consistency, with Cronbach's alpha of 0.95 for the FFM and 0.70 for the MFM. Mean (s.d.) test-retest differences were -0.31 (3.82) points for the FFM and -0.70 (4.26) points for the MFM. Eleven out of 13 a priori hypotheses relating both the FFM and MFM to demographic, disease and quality of life variables were confirmed, supporting the construct validity of these scales.
CONCLUSION: The FFM and MFM are valid and reliable measures of family and marital functioning in a multi-ethnic cohort of Asian SLE patients in Singapore.

Entities:  

Mesh:

Year:  1999        PMID: 10483028     DOI: 10.1191/096120399678840747

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Does being bilingual in English and Chinese influence changes in quality of life scale scores? Evidence from a prospective, population based study.

Authors:  Julian Thumboo; Yin-Bun Cheung; David Machin; Pao-Hsii Feng; Mee-Leng Boey; Szu-tien Thio; Kok-Yong Fong
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

2.  Modelling variability of quality of life scores: a study of questionnaire version and bilingualism.

Authors:  Y B Cheung; J Thumboo; D Machin; P H Feng; M L Boey; S T Thio; K Y Fong
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

3.  Determinants of Health-Related Quality of Life (HRQoL) in the Multiethnic Singapore Population - A National Cohort Study.

Authors:  Melvin Khee-Shing Leow; Konstadina Griva; Robin Choo; Hwee-Lin Wee; Julian Thumboo; E Shyong Tai; Stanton Newman
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

4.  Psychometric properties of a Chinese version of the medical outcomes study family and marital functioning measures in Hong Kong Chinese childbearing families.

Authors:  Fei-Wan Ngai; Siew-Fei Ngu
Journal:  Community Ment Health J       Date:  2011-10-18

5.  The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?

Authors:  Hwee-Lin Wee; Yin-Bun Cheung; Shu-Chuen Li; Kok-Yong Fong; Julian Thumboo
Journal:  Health Qual Life Outcomes       Date:  2005-01-12       Impact factor: 3.186

6.  Associations between disease awareness and health-related quality of life in a multi-ethnic Asian population.

Authors:  Kavita Venkataraman; ChinMeng Khoo; Hwee Lin Wee; Chuen Seng Tan; Stefan Ma; Derrick Heng; Jeannette Lee; E Shyong Tai; Julian Thumboo
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

7.  Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients.

Authors:  Hwee-Lin Wee; Benjamin Jun Jie Seng; Jia Jia Lee; Kok Joon Chong; Pallavi Tyagi; Anantharaman Vathsala; Priscilla How
Journal:  Health Qual Life Outcomes       Date:  2016-06-24       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.